Oracle (NYSE:ORCL) Price Target Lowered to $205.00 at Freedom Broker

Oracle (NYSE:ORCL) had its price target reduced by analysts at Freedom Broker from $210.00 to $205.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the enterprise software provider’s stock. Freedom Broker’s price objective would suggest a potential upside of 41.88% from the company’s current price.

ORCL has been the topic of several other research reports. Stephens reissued an “equal weight” rating and set a $175.00 target price on shares of Oracle in a research report on Friday. Guggenheim reiterated a “buy” rating and issued a $400.00 price target on shares of Oracle in a research note on Tuesday, September 8th. BMO Capital Markets cut their price objective on shares of Oracle from $220.00 to $195.00 and set an “outperform” rating on the stock in a report on Friday. Sanford C. Bernstein restated an “outperform” rating on shares of Oracle in a research report on Wednesday, September 2nd. Finally, Wedbush lowered their target price on shares of Oracle from $275.00 to $240.00 and set an “outperform” rating for the company in a report on Thursday, June 11th. Two research analysts have rated the stock with a Strong Buy rating, thirty have issued a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $253.95.

Oracle Stock Down 3.9%

Shares of ORCL stock traded down $5.80 on Monday, reaching $144.48. 41,870,948 shares of the stock were exchanged, compared to its average volume of 29,296,664. The company has a market capitalization of $416.18 billion, a price-to-earnings ratio of 22.65, a PEG ratio of 1.10 and a beta of 1.74. The business’s 50 day moving average price is $141.08 and its 200 day moving average price is $160.52. The company has a current ratio of 1.17, a quick ratio of 1.12 and a debt-to-equity ratio of 1.75. Oracle has a twelve month low of $114.50 and a twelve month high of $329.50.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.18. The company had revenue of $19.34 billion for the quarter, compared to analysts’ expectations of $19.13 billion. Oracle had a return on equity of 47.43% and a net margin of 26.36%.Oracle’s quarterly revenue was up 29.6% on a year-over-year basis. During the same period last year, the firm earned $1.47 earnings per share. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, sell-side analysts expect that Oracle will post 6.6 earnings per share for the current fiscal year.

Insider Activity

In other news, Vice Chairman Jeffrey Henley sold 400,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the transaction, the insider directly owned 400,000 shares in the company, valued at approximately $63,664,000. This trade represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 40.90% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. California State Teachers Retirement System raised its holdings in shares of Oracle by 14,636.4% in the second quarter. California State Teachers Retirement System now owns 382,756,945 shares of the enterprise software provider’s stock valued at $56,093,030,000 after buying an additional 380,159,589 shares during the last quarter. Geode Capital Management LLC increased its position in Oracle by 1.8% in the 4th quarter. Geode Capital Management LLC now owns 37,734,944 shares of the enterprise software provider’s stock valued at $7,328,754,000 after acquiring an additional 665,374 shares during the period. Capital Research Global Investors raised its stake in Oracle by 29.3% during the 4th quarter. Capital Research Global Investors now owns 30,137,126 shares of the enterprise software provider’s stock valued at $5,874,070,000 after acquiring an additional 6,826,299 shares during the last quarter. Norges Bank purchased a new stake in Oracle during the 4th quarter valued at approximately $4,336,031,000. Finally, Janus Henderson Group PLC lifted its position in Oracle by 8.6% during the 4th quarter. Janus Henderson Group PLC now owns 14,539,366 shares of the enterprise software provider’s stock worth $2,815,242,000 after acquiring an additional 1,148,698 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle’s fiscal first-quarter results exceeded expectations, with revenue of $19.35 billion, up 29.6% year over year, and EPS of $1.92 versus the $1.74 consensus estimate. Management also issued fiscal 2027 guidance, supporting the long-term growth case. After Beating Expectations in Q1, Is Oracle Stock Due to Rally Higher?
• Positive Sentiment: Oracle reported strong demand for its cloud infrastructure: more than 300,000 GPUs were added during the quarter, while fleet utilization remained near 98%. The data point reinforces the potential for Oracle Cloud Infrastructure to benefit from sustained AI demand. Oracle’s AI Chips Ran 97.9% Utilized Last Quarter
• Positive Sentiment: Analysts remain divided but several maintain bullish views. Barclays raised its price target to $252, while Argus reaffirmed a Buy rating with a $225 target. Larry Ellison’s cancellation of a planned sale of up to $7.5 billion of Oracle shares also removed a potential source of selling pressure. Barclays resets Oracle stock price target
• Neutral Sentiment: Oracle Health launched a clinical AI agent for U.S. inpatient nurses, expanding the company’s healthcare AI offerings and potentially supporting future product adoption. Oracle Health Clinical AI Agent Helps Nurses
• Negative Sentiment: Investors are increasingly worried that Oracle’s roughly $90 billion AI-related capital-spending plan will pressure free cash flow and increase leverage. The company has reportedly begun another round of layoffs while investing heavily in data centers, raising concerns about restructuring costs and the economics of its AI expansion. Oracle begins a new round of layoffs
• Negative Sentiment: The Ellison transaction created uncertainty because the sale plan was filed and canceled within roughly one day. Some investors interpreted the reversal as unusual, while broader technology-sector weakness, interest-rate concerns and discussion of greater AI oversight added to selling pressure. Why Oracle Stock Fell Quickly Today

Oracle Company Profile

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company’s products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.